Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about Covid-19's effect on the mental health of...
from NDTV News - Latest https://ift.tt/2PorIGJ
No comments:
Post a Comment